Align Technology (XTER:AFW) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 02, 2026)


XTER:AFW Align Technology Inc XTER:AFW
89 GF Score
Price €149.05
GF Value €197.07
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Align Technology Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2026-07-02), Align Technology's Predictability Rank is 3-Stars. Align Technology's intrinsic value calculated from the Discounted Dividend model is €282.91 and current share price is €149.05. Consequently,

Align Technology's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is N/A.

XTER:AFW vs SOLV, COO, BAX: Margin of Safety % (DCF Dividends Based) Comparison

For the Medical Instruments & Supplies subindustry, Align Technology's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Align Technology Margin of Safety % (DCF Dividends Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Align Technology's Margin of Safety % (DCF Dividends Based) falls into.


XTER:AFW
89GF Score
Align Technology Inc XTER:AFW
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Align Technology Margin of Safety % (DCF Dividends Based) Calculation

Align Technology's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(0.00-149.05)/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

Is Align Technology (XTER:AFW) Overvalued in 2026?

Based on GuruFocus' analysis, Align Technology stock appears to be undervalued. The current stock price of €149.05 is trading 24.4% below its estimated GF Value™ of €197.07. GuruFocus considers Align Technology to be Modestly Undervalued.

Key valuation signals for XTER:AFW:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: €197.07 vs. price of €149.05 (24.4% below fair value)
  • GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the XTER:AFW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Align Technology Business Description

Address 410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85288
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
89GF Score

Get the complete analysis for XTER:AFW

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€149.05
Price
€197.07
GF Value